Anti-CD20 Monoclonal Antibody (Rituximab) for the Treatment of Membranous Nephropathy After Living-Unrelated Kidney Transplantation: A Case Report

Transplantation Proceedings

Volumn 40, Issue 7, 2008, Pages 2440-2441

  Sirimongkolrat, T ^a   Premasathian, N ^a   Vongwiwatana, A ^a   Limsrichamrern, S ^a   Cheunsuchon, B ^a   Vasuvattakul, S ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; ENALAPRIL; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; SIMVASTATIN; VALSARTAN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; GRAFT VERSUS HOST REACTION; HEMODIALYSIS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL; CREATININE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOGLOBULIN M; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PROTEINURIA;

EID: 51249094920     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.074     Document Type: Article

References (9)

1. Berger B.E., Vincenti F., Biava C., et al. De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation 35 (1983) 315
2. Josephson M.A., Spargo B., Hollandsworth D., et al. The recurrence of recurrent membranous glomerulopathy in a renal-transplant recipient-case-report and literature-review. Am J Kidney Dis 24 (1994) 873
3. Truong L., Gelfand J., D'Agati V., et al. De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature. Am J Kidney Dis 14 (1989) 131
4. Briganti E.M., Russ G.R., McNeil J.J., et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347 (2002) 103
5. Joshi K., Nada R., Minz M., et al. Recurrent glomerulopathy in the renal allograft. Transplant Proce 39 (2007) 734
6. Ruggenenti P., Chiurchiu C., Brusegan V., et al. Rituximab in idiopathic membranous nephropathy: a one year prospective study. J Am Soc Nephrol 14 (2003) 1851
7. Gallona L., and Chhabra D. Anti-CD20 monoclonal antibody (Rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient. Am J Transplant 6 (2006) 3017
8. Douglas A., Tibor N., and Racusen L.C. Plasma cell-rich acute renal allograft rejection. Transplantation 68 (1999) 791
9. Salama A.D., and Pusey C.D. Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2 (2006) 221